Increased Hospitalizations and Death in Patients with ESRD Secondary to Lupus

Overview

Journal Lupus

Publisher Sage Publications

Specialty Rheumatology

Date 2012 Jun 28

PMID 22736748

Citations 9

Authors

S Sule

B Fivush

A Neu

S Furth

Affiliations

Soon will be listed here.

Abstract

Background: Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect almost any organ system, including the kidneys. Using a large national dataset, our goal was to compare the morbidity as measured by hospitalization and mortality rates between hemodialysis patients with end-stage renal disease (ESRD) secondary to SLE to those with ESRD due to other causes.

Methods: The risk of hospitalization was calculated by Poisson regression with clustering for repeated measures using the United States Renal Data System (USRDS) Hospitalization Analytic File in strata of pediatric and adult patients. Cox proportional hazard ratio was used to assess the mortality risk in hospitalized patients. Subjects were censored at transplantation or end of follow-up.

Results: Adult patients with ESRD secondary to SLE were hospitalized more frequently than other adults (incidence rate ratio (IRR): 1.43, 95% confidence interval (CI): 1.15-1.77) and had a higher risk of death (hazard ratio (HR): 1.89, 95% CI: 1.66-2.5). Mortality was higher in hospitalized pediatric patients with SLE compared to pediatric patients with other causes of ESRD (HR: 2.01, 95% CI: 1.75-2.31) and adults with SLE (HR: 2.05, 95% CI: 1.79-2.34).

Conclusion: Our study demonstrates that there is a trend toward increased hospitalization rates in pediatric and adult patients with SLE. Among these hospitalized patients with SLE, there is an increased risk of death due to cardiovascular disease.

Citing Articles

Role of the transcription factor Fli-1 on the CXCL10/CXCR3 Axis.

Wang X, Richard M, Caldwell T, Sundararaj K, Sato S, Nowling T Front Immunol. 2023; 14:1219279.

PMID: 37790939 PMC: 10543418. DOI: 10.3389/fimmu.2023.1219279.

Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease.

Guerrero M, Jimenez A, Dobrowolski C, Mowrey W, Goilav B, Wang S BMC Nephrol. 2020; 21(1):450.

PMID: 33115441 PMC: 7592532. DOI: 10.1186/s12882-020-02083-2.

Primary causes of kidney disease and mortality in dialysis-dependent children.

Okuda Y, Soohoo M, Ishikura K, Tang Y, Obi Y, Laster M Pediatr Nephrol. 2020; 35(5):851-860.

PMID: 32020338 PMC: 8876253. DOI: 10.1007/s00467-019-04457-7.

Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study.

Jorge A, Wallace Z, Lu N, Zhang Y, Choi H Ann Intern Med. 2019; 170(4):240-247.

PMID: 30665236 PMC: 6739121. DOI: 10.7326/M18-1570.

Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System.

Broder A, Mowrey W, Izmirly P, Costenbader K Arthritis Care Res (Hoboken). 2016; 69(4):599-604.

PMID: 27390299 PMC: 5219868. DOI: 10.1002/acr.22972.

References

Cheng J, Ke Q, Jin Z, Wang H, Kocher O, Morgan J . Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog. 2009; 5(5):e1000427. PMC: 2673691. DOI: 10.1371/journal.ppat.1000427. View

Jimenez S, Cervera R, Font J, Ingelmo M . The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003; 25(1):3-12. DOI: 10.1385/CRIAI:25:1:3. View

Roman M, Shanker B, Davis A, Lockshin M, Sammaritano L, Simantov R . Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003; 349(25):2399-406. DOI: 10.1056/NEJMoa035471. View

Kamphuis S, Silverman E . Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010; 6(9):538-46. DOI: 10.1038/nrrheum.2010.121. View

Foley R, Collins A . End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007; 18(10):2644-8. DOI: 10.1681/ASN.2007020220. View

Asanuma Y, Kawai S, Aoshima H, Kaburaki J, Mizushima Y . Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis. Arthritis Rheum. 1999; 42(3):443-7. DOI: 10.1002/1529-0131(199904)42:3<443::AID-ANR8>3.0.CO;2-Q. View

Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B . Infectious antibodies in systemic lupus erythematosus patients. Lupus. 2009; 18(13):1129-35. DOI: 10.1177/0961203309345729. View

Sule S, Fivush B, Neu A, Furth S . Increased risk of death in pediatric and adult patients with ESRD secondary to lupus. Pediatr Nephrol. 2010; 26(1):93-8. PMC: 2992078. DOI: 10.1007/s00467-010-1640-9. View

Ward M . Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?. J Rheumatol. 2002; 29(6):1198-206. View

10.

Shang Q, Tam L, Li E, Yip G, Yu C . Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Lupus. 2008; 17(12):1096-102. DOI: 10.1177/0961203308092160. View

11.

Helmick C, Felson D, Lawrence R, Gabriel S, Hirsch R, Kwoh C . Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008; 58(1):15-25. DOI: 10.1002/art.23177. View

12.

Krishnan E . Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol. 2006; 33(9):1770-4. View

13.

Stichweh D, Arce E, Pascual V . Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol. 2004; 16(5):577-87. DOI: 10.1097/01.bor.0000137852.42270.0f. View

14.

Schanberg L, Sandborg C, Barnhart H, Ardoin S, Yow E, Evans G . Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009; 60(5):1496-507. PMC: 2770725. DOI: 10.1002/art.24469. View

15.

Urowitz M, Gladman D, Tom B, Ibanez D, Farewell V . Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008; 35(11):2152-8. DOI: 10.3899/jrheum.080214. View

16.

Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J . Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol. 2003; 19(1):36-44. DOI: 10.1007/s00467-003-1278-y. View

17.

Grattan M, Starnes V, Oyer P, Stinson E, Shumway N . Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989; 261(24):3561-6. View

18.

Petri M, Perez-Gutthann S, Spence D, Hochberg M . Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med. 1992; 93(5):513-9. DOI: 10.1016/0002-9343(92)90578-y. View